Kenneth Hoberman has an estimated net worth of $12.2 Million. This is based on reported shares across multiple companies, which include Nuvectis Pharma, Inc., TG THERAPEUTICS, INC., and STEMLINE THERAPEUTICS INC.

2016 was Kenneth Hoberman's most active year for acquiring shares with 5 total transactions. Kenneth Hoberman's most active month to acquire stocks was the month of May. 2019 was Kenneth Hoberman's most active year for disposing of shares, totalling 13 transactions. Kenneth Hoberman's most active month to dispose stocks was the month of February. 2015 saw Kenneth Hoberman paying a total of $110,859.45 for 125,352 shares, this is the most they've acquired in one year. In 2019 Kenneth Hoberman cashed out on 172,425 shares for a total of $2,168,902.40, their largest year based on trade value.